$2.19
-0.075-3.32%
Last update: Oct 16, 11:38 AM
$2.30
0.041.77%
Ovid Therapeutics Inc
OVIDNASDAQ
Wall Street analyst price targets and consensus rating for Ovid Therapeutics (OVID).
Price Target Range — 11 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
